Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

The Angels Initiative

Stroke prevention


  Free Subscription

Articles published in J Clin Oncol

Retrieve available abstracts of 30 articles:
HTML format

Single Articles

    July 2022
  1. LEE CH, Voss MH, Carlo MI, Chen YB, et al
    Phase II Trial of Cabozantinib Plus Nivolumab in Patients With Non-Clear-Cell Renal Cell Carcinoma and Genomic Correlates.
    J Clin Oncol. 2022;40:2333-2341.
    PubMed     Abstract available

    June 2022
  2. HOL JA, Kuiper RP, van Dijk F, Waanders E, et al
    Prevalence of (Epi)genetic Predisposing Factors in a 5-Year Unselected National Wilms Tumor Cohort: A Comprehensive Clinical and Genomic Characterization.
    J Clin Oncol. 2022;40:1892-1902.
    PubMed     Abstract available

  3. GWEE YX, Chia DKA, So J, Ceelen W, et al
    Integration of Genomic Biology Into Therapeutic Strategies of Gastric Cancer Peritoneal Metastasis.
    J Clin Oncol. 2022 Jun 1:JCO2102745. doi: 10.1200/JCO.21.02745.
    PubMed     Abstract available

    April 2022
  4. KURRECK A, Stintzing S, Modest DP
    Efficacy, Molecular Biology, Quality of Life, or Economic Aspects: What Do We Really FOCUS oN?
    J Clin Oncol. 2022;40:1260-1262.

  5. CHAKRAVARTY D, Johnson A, Sklar J, Lindeman NI, et al
    Somatic Genomic Testing in Patients With Metastatic or Advanced Cancer: ASCO Provisional Clinical Opinion.
    J Clin Oncol. 2022;40:1231-1258.
    PubMed     Abstract available

    February 2022
  6. CARLOS RC, Obeng-Gyasi S, Cole SW, Zebrack BJ, et al
    Linking Structural Racism and Discrimination and Breast Cancer Outcomes: A Social Genomics Approach.
    J Clin Oncol. 2022 Feb 2:JCO2102004. doi: 10.1200/JCO.21.02004.

    December 2021
  7. SABNIS HS, Shulman DS, Mizukawa B, Bouvier N, et al
    Multicenter Analysis of Genomically Targeted Single Patient Use Requests for Pediatric Neoplasms.
    J Clin Oncol. 2021;39:3822-3828.
    PubMed     Abstract available

    November 2021
  8. NAZHA A, Komrokji R, Meggendorfer M, Jia X, et al
    Personalized Prediction Model to Risk Stratify Patients With Myelodysplastic Syndromes.
    J Clin Oncol. 2021;39:3737-3746.
    PubMed     Abstract available

    October 2021
  9. ADEMUYIWA FO, Salyer P, Tao Y, Luo J, et al
    Genetic Counseling and Testing in African American Patients With Breast Cancer: A Nationwide Survey of US Breast Oncologists.
    J Clin Oncol. 2021 Oct 18:JCO2101426. doi: 10.1200/JCO.21.01426.
    PubMed     Abstract available

    September 2021
    A Step Forward in Realizing the Promise of Genomic Medicine for Childhood Rhabdomyosarcoma.
    J Clin Oncol. 2021;39:2851-2854.

  11. SHERN JF, Selfe J, Izquierdo E, Patidar R, et al
    Genomic Classification and Clinical Outcome in Rhabdomyosarcoma: A Report From an International Consortium.
    J Clin Oncol. 2021;39:2859-2871.
    PubMed     Abstract available

    April 2021
  12. BERSANELLI M, Travaglino E, Meggendorfer M, Matteuzzi T, et al
    Classification and Personalized Prognostic Assessment on the Basis of Clinical and Genomic Features in Myelodysplastic Syndromes.
    J Clin Oncol. 2021;39:1223-1233.
    PubMed     Abstract available

  13. MURPHY AB, Abern MR, Liu L, Wang H, et al
    Impact of a Genomic Test on Treatment Decision in a Predominantly African American Population With Favorable-Risk Prostate Cancer: A Randomized Trial.
    J Clin Oncol. 2021 Apr 9:JCO2002997. doi: 10.1200/JCO.20.02997.
    PubMed     Abstract available

    February 2021
  14. CREW KD, Hershman DL
    Better Together: Clinical and Genomic Data to Inform Shared Decision Making.
    J Clin Oncol. 2021;39:545-547.

    January 2021
  15. KUMAR R, Smith KS, Deng M, Terhune C, et al
    Clinical Outcomes and Patient-Matched Molecular Composition of Relapsed Medulloblastoma.
    J Clin Oncol. 2021 Jan 27:JCO2001359. doi: 10.1200/JCO.20.01359.
    PubMed     Abstract available

  16. KALINSKY K, Thomas A, Cescon DW
    On the Road to Precision: Understanding the Biology Driving Genomic Assays.
    J Clin Oncol. 2021;39:100-102.

  17. GAJJAR A, Robinson GW, Smith KS, Lin T, et al
    Outcomes by Clinical and Molecular Features in Children With Medulloblastoma Treated With Risk-Adapted Therapy: Results of an International Phase III Trial (SJMB03).
    J Clin Oncol. 2021 Jan 6:JCO2001372. doi: 10.1200/JCO.20.01372.
    PubMed     Abstract available

    November 2020
  18. AMBROS IM, Tonini GP, Potschger U, Gross N, et al
    Age Dependency of the Prognostic Impact of Tumor Genomics in Localized Resectable MYCN-Nonamplified Neuroblastomas. Report From the SIOPEN Biology Group on the LNESG Trials and a COG Validation Group.
    J Clin Oncol. 2020;38:3685-3697.
    PubMed     Abstract available

    October 2020
  19. CROMBIE JL, Armand P
    Diffuse Large B-Cell Lymphoma's New Genomics: The Bridge and the Chasm.
    J Clin Oncol. 2020;38:3565-3574.

    July 2020
  20. LONIAL S, Dhodapkar MV, Rajkumar SV
    Smoldering Myeloma and the Art of War.
    J Clin Oncol. 2020;38:2363-2365.

  21. BUSTOROS M, Sklavenitis-Pistofidis R, Park J, Redd R, et al
    Genomic Profiling of Smoldering Multiple Myeloma Identifies Patients at a High Risk of Disease Progression.
    J Clin Oncol. 2020;38:2380-2389.
    PubMed     Abstract available

    May 2020
  22. LIN DW, Zheng Y, McKenney JK, Brown MD, et al
    17-Gene Genomic Prostate Score Test Results in the Canary Prostate Active Surveillance Study (PASS) Cohort.
    J Clin Oncol. 2020;38:1549-1557.
    PubMed     Abstract available

  23. KURIAN AW, Katz SJ
    Emerging Opportunity of Cascade Genetic Testing for Population-Wide Cancer Prevention and Control.
    J Clin Oncol. 2020;38:1371-1374.

  24. FREY MK, Kahn RM, Chapman-Davis E, Tubito F, et al
    Prospective Feasibility Trial of a Novel Strategy of Facilitated Cascade Genetic Testing Using Telephone Counseling.
    J Clin Oncol. 2020;38:1389-1397.
    PubMed     Abstract available

    April 2020
  25. ROBINSON GW, Gajjar A
    Genomics Paves the Way for Better Infant Medulloblastoma Therapy.
    J Clin Oncol. 2020 Apr 30:JCO2000593. doi: 10.1200/JCO.20.00593.

  26. TREON SP, Xu L, Guerrera ML, Jimenez C, et al
    Genomic Landscape of Waldenstrom Macroglobulinemia and Its Impact on Treatment Strategies.
    J Clin Oncol. 2020;38:1198-1208.
    PubMed     Abstract available

    March 2020
  27. FREEMAN S, Craddock C
    Less Is Not Necessarily More: Toward a Rational Selection of the Conditioning Regimen in Acute Myeloid Leukemia.
    J Clin Oncol. 2020 Mar 2:JCO1903161. doi: 10.1200/JCO.19.03161.

    February 2020
  28. HASSETT MJ, Somerfield MR, Baker ER, Cardoso F, et al
    Management of Male Breast Cancer: ASCO Guideline.
    J Clin Oncol. 2020 Feb 14:JCO1903120. doi: 10.1200/JCO.19.03120.
    PubMed     Abstract available

    January 2020
  29. KONSTANTINOPOULOS PA, Norquist B, Lacchetti C, Armstrong D, et al
    Germline and Somatic Tumor Testing in Epithelial Ovarian Cancer: ASCO Guideline.
    J Clin Oncol. 2020 Jan 27:JCO1902960. doi: 10.1200/JCO.19.02960.
    PubMed     Abstract available

    December 2019
  30. EGGENER SE, Rumble RB, Armstrong AJ, Morgan TM, et al
    Molecular Biomarkers in Localized Prostate Cancer: ASCO Guideline.
    J Clin Oncol. 2019 Dec 12:JCO1902768. doi: 10.1200/JCO.19.02768.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Genetics is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.